Cancer affects walking through multiple mechanisms depending on the cancer type, location, treatment received, and disease stage. This article addresses two specific cancer-related walking challenges that are under-served by general walking aid guidance: cancer-related fatigue (CRF) and bone metastases causing skeletal walking impairment.
Cancer-Related Fatigue (CRF)
Cancer-related fatigue is one of the most prevalent symptoms across cancer types and treatments, affecting up to 90% of patients during active treatment and persisting in up to 30% of cancer survivors. CRF is distinct from normal fatigue:
- Not relieved by rest
- Disproportionate to activity level
- Multifactorial -- caused by the cancer itself, chemotherapy, radiotherapy, anaemia, poor nutrition, and sleep disturbance
- Walking capacity is often severely limited -- patients who were previously active find themselves unable to walk more than a short distance
A walking cane in CRF functions as an energy economy device -- reducing the metabolic cost per step, extending the walkable distance before the fatigue threshold is reached. For cancer patients in active treatment who are trying to maintain functional mobility and comply with physical activity recommendations (moderate exercise during chemotherapy is beneficial and may improve outcomes), a cane that enables more walking than would otherwise be possible has direct health implications beyond simple mobility.
Bone Metastases and Walking
Many cancers (breast, prostate, lung, kidney, thyroid, myeloma) commonly metastasise to bone. The implications for walking depend on the location and extent of metastatic disease:
- Femur metastases: Cortical bone destruction at the femoral shaft or neck increases the risk of pathological fracture -- a fracture occurring with minimal force. Weight-bearing on a femur with impending fracture risk is a clinical emergency. A walking cane in this context is NOT sufficient protection -- unprotected weight-bearing on an at-risk femur may trigger fracture. This requires orthopaedic assessment (possible prophylactic nailing or radiotherapy)
- Vertebral metastases: Spinal cord compression from vertebral metastases is an oncological emergency. Back pain with leg weakness or sensory symptoms requires urgent investigation. A walking cane does not protect against spinal cord compression
- Pelvic and hip metastases: Pain and weakening of the acetabulum or ilium impairs walking. Cane use reduces load on the affected side
- Tibial and other long bone metastases: Similar pathological fracture risk assessment needed
CRF and Bone Metastases: Cane Use
| Situation | Walking Impact | Cane Role and Safety |
|---|---|---|
| CRF (active treatment) | Profound fatigue limits walking range | Energy economy; enables minimal activity compliance |
| CRF (post-treatment survivor) | Persistent fatigue, reduced endurance | Gradual activity increase; cane enables longer sessions |
| Bone metastases (no fracture risk) | Bone pain, local weakness | Load reduction from painful metastatic site |
| Impending pathological fracture (femur) | Fracture risk on weight-bearing | Cane INSUFFICIENT -- urgently seek orthopaedic assessment |
Explore the DaiWalk cane collection. Related: Walking Cane for Chronic Fatigue | Walking Cane for Bone Disease
